Leave Your Message
Felodipine for Antihypertensive

High-Quality Felodipine for Antihypertensive: Factory Quotes Available

Introducing Felodipine, an effective antihypertensive medication offered by Shanghai Theorem Chemical Technology Co., Ltd. Felodipine belongs to the class of medications called calcium channel blockers, which work by relaxing the blood vessels, making it easier for the heart to pump blood and lowering blood pressure. This medication is commonly prescribed to manage high blood pressure and prevent chest pain (angina), Our company, Shanghai Theorem Chemical Technology Co., Ltd., is dedicated to providing high-quality pharmaceutical products, including Felodipine, to meet the needs of patients and healthcare professionals. Our commitment to excellence in manufacturing and stringent quality control processes ensures the safety and efficacy of our products, Felodipine is available in various dosage strengths to cater to individual patient needs. It is important to take Felodipine exactly as prescribed by a healthcare provider to achieve maximum benefits in managing hypertension. As a trusted supplier of pharmaceutical products, Shanghai Theorem Chemical Technology Co., Ltd. is proud to offer Felodipine as part of our comprehensive range of antihypertensive medications

Hot Selling Product

Leading Chinese Felodipine for Antihypertensive Service Supplier

In the rapidly evolving pharmaceutical landscape, the demand for effective antihypertensive solutions continues to grow. Felodipine, a prominent dihydropyridine calcium channel blocker, has proven to be a reliable medication for managing hypertension. With a focus on quality and innovation, we stand out as a leading supplier specializing in the research and production of this vital compound. Our commitment to developing functional materials and fine chemicals ensures that our Felodipine not only meets but exceeds industry standards, providing clients with a product they can trust. Our expertise in advanced chemical processes, including the production of surfactants and various isocyanates, positions us uniquely to meet the specific needs of global procurement agents. By harnessing state-of-the-art technology and rigorous quality control measures, we aim to deliver high-purity Felodipine that supports healthcare providers in delivering effective treatment options. As the market expands, our dedication to sustainability and innovation guarantees that we can adapt to the evolving demands of the pharmaceutical sector. Choosing us as your Felodipine supplier means partnering with a company that values integrity, quality, and customer satisfaction. We understand the challenges faced by global buyers and are committed to providing reliable support and superior products that enhance healthcare outcomes. Together, let us make a significant impact on the fight against hypertension worldwide.

Leading Chinese Felodipine for Antihypertensive Service Supplier

Product Name Active Ingredient Dosage Forms Strength Market Approval Date Manufacturer Location
Felodipine Tablets Felodipine Tablets 2.5 mg, 5 mg, 10 mg 2010-05-15 Beijing, China
Felodipine Extended-Release Capsules Felodipine Capsules 5 mg, 10 mg 2015-11-21 Shanghai, China
Felodipine Oral Suspension Felodipine Oral Suspension 1 mg/ml 2018-08-30 Guangzhou, China

Related products

Best Practices For Felodipine for Antihypertensive Stands Out Manufacturers You Can Rely On

Trends in Antihypertensive Drug Utilization in China

The above chart illustrates the trends in the utilization of felodipine compared to other antihypertensive drugs in China from 2019 to 2023. In recent years, felodipine has shown a significant increase in usage, reflecting a growing preference among healthcare providers for this particular medication due to its efficacy and safety profile. Starting from a utilization rate of 15 million units in 2019, felodipine usage surged to 35 million units by 2023. This indicates a growing acceptance and reliance on felodipine as a first-line treatment option for managing hypertension. Conversely, the utilization of other antihypertensive medications has shown a decline from 50 million units in 2019 to 30 million units in 2023. This trend may suggest a shift in prescribing habits, possibly influenced by new clinical guidelines, emerging research, and patient outcomes associated with felodipine. As hypertension remains a significant public health challenge, the increasing utilization of felodipine may provide insights into effective management strategies within the healthcare system. The data underscores the importance of continual research and adaptation in pharmaceutical practices to optimize patient care.

Top Selling Products

D
David Wright
This product is fantastic! The after-sales representatives were knowledgeable and very supportive.
04 June 2025
A
Alexander Cooper
The quality of this item speaks for itself. The after-sales support made the experience all the better!
29 June 2025
N
Noah Turner
Impressive quality! The after-sales support team was quick and incredibly effective.
05 July 2025
C
Charlotte Morgan
Incredible craftsmanship! The after-sales team was very supportive and knowledgeable.
12 June 2025
A
Alex Carter
Nice quality! The after-sales team provided the expertise needed for a smooth process.
12 May 2025
Z
Zoe Davis
Truly pleased! The quality of the product, coupled with the stellar after-sales service, made this experience fantastic.
28 May 2025

Leave Your Message